An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: The diagnostic approach

Netherlands Journal of Medicine

Volumn 69, Issue 1, 2011, Pages 14-20

  Kuiper, P ^a   Verspaget, H W ^a   Overbeek, L I H ^b   Biemond, I ^a   Lamers, C B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Foundation PALGA   (Netherlands)

Author keywords

Carcinoid; Diagnosis; Gastrointestinal; Neuroendocrine tumour; Pancreas

Indexed keywords

CHROMOGRANIN A;

CANCER DIAGNOSIS; CANCER INCIDENCE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; GASTROINTESTINAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MORBIDITY; NETHERLANDS; NEUROENDOCRINE TUMOR; NEUROENDOCRINE TUMOR OF THE GASTROENTEROPANCREATIC TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; REVIEW; URINALYSIS;

GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; NETHERLANDS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RARE DISEASES;

EID: 79952088843     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008; 9:61-72.
2. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumours: pancreatic endocrine tumours. Gastroenterology. 2008;135:1469-92.
3. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumours. Oncologist. 2008;13:1255-69.
4. Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumours. Virchows Arch. 2007;451(Suppl 1):S9-S27.
5. Starker LF, Carling T. Molecular genetics of gastroenteropancreatic neuroendocrine tumours. Curr Opin Oncol. 2009;21:29-33.
6. Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumours. J Natl Cancer Inst. 2008;100:1282:89.
7. Halfdanarson TR, Rabe KG, Rubin J, et al. Pancreatic neuroendocrine tumours (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19:1727-33.
8. Kuiper P, Verspaget HW, van Slooten HJ, Overbeek L, Biemond I, Lamers CB. The pathological incidence of duodeno-pancreatic neuroendocrine tumours in The Netherlands. Pancreas (in press).
9. Franko J, Feng W, Yip L, et al. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumour biology, and outcomes in 2,158 patients. J Gastrointest Surg. 2010;14:541-8.
10. Landerholm K, Falkmer S, Järhult J. Epidemiology of small bowel carcinoids in a defined population. World J Surg. 2010;34:1500-5.
11. Casparie M, Tiebosch ATMG., Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cellular Oncol. 2007;29:19-24.
12. www.oncoline.nl
13. Klöppel G, Couvelard A, Perren A, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumours: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumours and their prognostic stratification. Neuroendocrinology. 2009;90:162-6.
14. Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol. 2001;12(Suppl 2):S69-S72.
15. Portel-Gomes GM, Grimelius L, Johansson H, Wilander E, Stridsberg M. Chromogranin A in human neuroendocrine tumours: an immunohistochemical study with region-specific antibodies. Am J Surg Pathol. 2001;25(10):1261-7.
16. Rockal AG, Reznek RH. Imaging of neuroendocrine tumours (CT/MR/US). Best Pract Res Clin Endocrinol Metab. 2007;21:43-68.
17. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumours: the WHO classification. Ann N Y Acad Sci. 2004;1014:13-27.
18. Oberndorfer S. Karzinoide Tumouren des Dunndarms. Frankf Z Pathol. 1907;1:425-9.
19. Soga J. The term "carcinoid" is a misnomer: the evidence based on local invasion. J Exp Clin Cancer Res. 2009;28:15.
20. Rindi G, Klöppel G. Endocrine tumours of the gut and pancreas tumour biology and classification. Neuroendocrinology. 2004;80(Suppl 1):12-5.
21. Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19:753-81.
22. Warner RR. Enteroendocrine tumours other than carcinoid: a review of clinically significant advances. Gastroenterology. 2005;128:1668-84.
23. Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Arch Pathol Lab Med. 2008;132:1285-9.
24. Wu PC, Alexander HR, Bartlett DL, et al. A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma. Surgery. 1997;122:1176-82.
25. Kuiper P, Biemond I, Verspaget HW, Lamers CB. A case of recurrent gastrinoma in the liver with a review of "primary" hepatic gastrinomas. BMJ Case Reports. 2009 online.
26. Ferolla P, Faggiano A, Avenia N, et al. Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours. Clin Endocrinol. (Oxf) 2007;66:1-6.
27. Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumours: clarifying these clinical conundrums. World J Surg. 2005;29:92-101.
28. Petrou A, Papalambros A, Papaconstantinou I, et al. Gastric carcinoid tumour in association with hepatocellular carcinoma: a case report. South Med J. 2008;101:1170-2.
29. Hung CY, Chen MJ, Shih SC, et al. Gastric carcinoid tumour in a patient with a past history of gastrointestinal stromal tumour of the stomach. World J Gastroenterol. 2008;14:6884-7.
30. Boutros C, Cheng-Robles D, Goldenkranz R. Intestinal neuroendocrine tumour in a patient with pituitary adenoma. A case report and review of the current screening recommendations. J Med Case Reports. 2007;1:140.
31. Lin YL, Wei CK, Chiang JK, Chou AL, Chen CW, Tseng CE. Concomitant gastric carcinoid and gastrointestinal stromal tumours: a case report. World J Gastroenterol. 2008;14:6100-3.
32. McHugh SM, O'Donnell J, Gillen P. Synchronous association of rectal adenocarcinoma and three ileal carcinoids: a case report. World J Surg Oncol. 2009;7:21.
33. Kidd M, Modlin IM, Mane SM, Camp RL, Shapiro MD. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumour disease. Ann Surg. 2006;243:273-80.
34. Modlin IM, Gustafsson BI, Drozdov I, Nadler B, Pfragner R, Kidd M. Principal component analysis, hierachical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumours. Ann Surg Oncol. 2009;16:487-98.
35. Long KB, Srivastava A, Hirsch MS, Hornick JL. PAX8 Expression in well-differentiated pancreatic endocrine tumours: a correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumours. Am J Surg Pathol. 2010;34:723-9.
36. Hosoda W, Takagi T, Mizuno N, et al. Diagnostic approach to pancreatic tumours with the specimens of endoscopic ultrasound-guided fine needle aspiration. Pathol Int. 2010;60:358-64.
37. Burford H, Baloch Z, Liu X, Jhala D, Siegal GP, Jhala N. E-cadherin/ beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas. Am J Clin Pathol. 2009;132:831-9.
38. Srivastava A, Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumours from pancreatic endocrine and pulmonary carcinoid tumours. Am J Surg Pathol. 2009;33:626-32.
39. Fendrich V, Ramerth R, Waldmann J, et al. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas. Endocr Relat Cancer. 2009;16:613-22.
40. Ishikawa T, Itoh A, Kwashima H, et al. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumours. Gastrointest Endosc. 2010;71:951-9.
41. Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M. Chromogranin a-biological function and clinical utility in neuro endocrine tumour disease. Ann Surg Oncol. 2010;17:2427-43.
42. Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging. 2010;37:67-77
43. Toumpanakis CG, Caplin ME. Molecular genetics of gastroenteropancreatic neuroendocrine tumours. Am J Gastroenterol. 2008;103:729-32.
44. Oberg K. Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumours (gastroenteropancreatic neuroendocrine tumours) Curr Opin Endocrinol Diabetes Obes. 2009;16:72-8.
45. Kuiper P, Biemond I, Masclee AA, Jansen JB, Verspaget HW, Lamers CB. Diagnostic efficacy of the secretin stimulation test for the Zollinger-Ellison syndrome: an intra-individual comparison using different dosages in patients and controls. Pancreatology. 2010;10:14-8.